Award

Hematology & Transfusion Medicine

Description: Duke’s training program in Hematology and Transfusion Medicine is dedicated to expanding the number and quality of research scientists pursuing research careers in blood disorders. We provide a comprehensive training program that allows trainees interested in blood research to become independent investigators and contribute to scientific advances to improve the health of millions of people with acquired blood disorders.

Funder: National Heart, Lung, and Blood Institute

Funding type: training

Funder scheme: T32

Start date: 1975-07-01

End date: 2026-06-30

Investigator: GOWTHAMI M AREPALLY

Institution: DUKE UNIVERSITY

Funded outputs count: 133

Funder award ID: T32HL007057

OpenAlex ID: G9000896211

Glutamine-driven reductive TCA cycle metabolism supports aged muscle stem cell function via de novo lipogenesis

2026 · David E. Lee, Lauren K. McKay, et al. · Nature Aging · 3

The pyruvate kinase activator etavopivat (FT-4202) limits pulmonary and systemic sequelae of sepsis in a mouse LPS model

2026 · Youwei Chen, Hongmei Zhu, et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology

Monitoring treatment response using an ultra-sensitive ctDNA assay in advanced esophagogastric cancer patients

2026 · Andrew B. Nixon, Fábio C. P. Navarro, et al. · Scientific Reports · 1

Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative Study

2025 · Marie-Michèle Sainvil, Ashley L. Artese, et al. · Transplantation and Cellular Therapy · 1

The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia

2025 · Timothy E. O’Connor, Chenyu Lin, et al. · Bone Marrow Transplantation · 1

A first-in-class EGFR-directed KRAS G12V selective inhibitor

2025 · Lyla J. Stanland, Hayden P. Huggins, et al. · Cancer Cell · 31

Snord67 promotes breast cancer metastasis by guiding U6 modification and modulating the splicing landscape

2025 · Yvonne L. Chao, Katherine I. Zhou, et al. · Nature Communications · 6

Outcomes of myeloablative allogeneic hematopoietic cell transplantation with omidubicel vs alternative donor sources

2025 · Chenyu Lin, Smitha Sivaraman, et al. · Blood Neoplasia · 1

Prospective psychometric validation of the Swahili translated and adapted Pediatric Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE)

2025 · Hutton Chapman, Jacqueline Kamanga, et al. · Measurement and Evaluations in Cancer Care · 1

Ultra-sensitive, tumor-informed ctDNA profiling in pembrolizumab-treated esophagogastric cancer patients predicts clinical responses

2024 · Andrew B. Nixon, Fábio C. P. Navarro, et al. · Research Square · 1

Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantation

2024 · Ashley L. Artese, Michele Sainvil, et al. · Supportive Care in Cancer · 3

Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis

2024 · Amneet Bajwa, Qiuhong Zhao, et al. · Blood Advances · 50

Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies Identifies Variants That Can Alter Clinical Practice

2024 · Chenyu Lin, Katherine I. Zhou, et al. · Hematology Reports

Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction

2024 · Chenyu Lin, Clare E. Anderson, et al. · British Journal of Haematology

Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis

2024 · Andrew E. Whiteley, Danhui Ma, et al. · Science · 85

Modulation of the allosteric and vasoregulatory arms of erythrocytic oxygen transport

2024 · Thomas J. Wise, Maura E. Ott, et al. · Frontiers in Physiology · 8

Brief Report: Real-World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C-Mutated NSCLC

2024 · Katherine I. Zhou, Chenyu Lin, et al. · JTO Clinical and Research Reports · 7

2′- O -methylation (Nm) in RNA: progress, challenges, and future directions

2024 · Katherine I. Zhou, Chad V. Pecot, et al. · RNA · 54

Liver-derived plasminogen mediates muscle stem cell expansion during caloric restriction through the plasminogen receptor Plg-RKT

2024 · Akshay Bareja, David E. Lee, et al. · Cell Reports · 12

Sickle red blood cells directly activate neutrophils

2024 · Grace M. Lee, Milena Batchvarova, et al. · British Journal of Haematology · 2

Management of Microsatellite Instability High (MSI-H) Gastroesophageal Adenocarcinoma

2023 · Katherine I. Zhou, Brent A. Hanks, et al. · Journal of Gastrointestinal Cancer · 11

Surprise diagnosis of acquired von Willebrand syndrome in a patient previously thought to have type III von Willebrand disease: evaluation and periprocedural management

2023 · Katherine Ismei Zhou, Sargam Kapoor, et al. · BMJ Case Reports · 1

Multi-omic rejuvenation and lifespan extension on exposure to youthful circulation

2023 · Bohan Zhang, David E. Lee, et al. · Nature Aging · 134

Dasatinib-associated follicular lymphoma in a patient with B-cell acute lymphoblastic leukaemia

2023 · Katherine Ismei Zhou, Chenyu Lin, et al. · BMJ Case Reports · 1

Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials

2023 · Chenyu Lin, Aurelie Schwarzbach, et al. · Transplantation and Cellular Therapy · 16